[Treatment of Le Peyronie's disease combining pharmacology and physical therapy].
Of the multiple conservative treatment modalities available for plastic induration of the corpora cavernosa, we chose to combine physical (laser therapy) and drug therapy (potaba) in an attempt to achieve a synergistic effect. We report on 32 cases submitted to this combined treatment modality. Patients were evaluated for pain, curvature, impotence and plaque before and after treatment.
Seres Figueras
A
A
D000328:Adult; D000368:Aged; D062365:Aminobenzoates / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D053685:Laser Therapy; D008297:Male; D008833:Microcirculation / Q000528:radiation effects; D008875:Middle Aged; D010101:Oxygen Consumption / Q000187:drug effects; D010411:Penile Induration / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D010413:Penis / Q000098:blood supply / Q000378:metabolism
D062365:Aminobenzoates; D000894:Anti-Inflammatory Agents, Non-Steroidal; D005343:Fibrinolytic Agents
Tratamiento de la enfermedad de Le Peyronie combinando farmacología y terapia fisica.